Atlas Trials

Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI

Clinical trial NCT00715455 · COMPLETED

Trial details

NCT number
NCT00715455
Sponsor
Regado Biosciences, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2007-10-01
Primary completion
2008-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.